SectorBiological Technology
Established Date--
Listing Date07/01/1999
ExchangeNASDAQ Stock Exchange
Full-time Employees6
Fiscal Year Ends30/06
Security TypeDepository Receipts (Ordinary Shares)
Office addressThree International Towers, Level 24, 300 Barangaroo Avenue, Sydney, New South Wales 2000, Australia
Business
IntroductionKazia Therapeutics Limited was established in March 1994 and is registered in New South Wales, Australia. The company is engaged in drug development, with a primary focus on oncology. Kazia is an emerging biotechnology business with a portfolio of development candidates spanning multiple technologies that aim to advance innovative therapies for a variety of cancer indications and provide new therapies that address unmet medical needs.
